Ceftriaxone can increase the expression and biochemical and functional activity of EAAT2 in animal brains and play a neuroprotective role in animal disease models based on glutamate toxicity, such as ischemic brain injury, motor neuron degeneration, amyotrophic lateral sclerosis (ALS).123. This evidence concerns the gene SLC1A2 and brain injury.